We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Neon Therapeutics Inc | NASDAQ:NTGN | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 3.07 | 3.00 | 3.46 | 0 | 01:00:00 |
A live webcast of the presentation will be available by visiting the Investors section of Neon Therapeutics’ website at ir.neontherapeutics.com. A replay of the webcast will be archived on the Neon Therapeutics website for 30 days following the presentation.
About Neon Therapeutics
Neon Therapeutics is a clinical-stage immuno-oncology company and a leader in the field of neoantigen-targeted therapies, dedicated to transforming the treatment of cancer by directing the immune system towards neoantigens. Neon is using its neoantigen platform to develop both vaccine and T cell therapies, including NEO-PV-01, a clinical stage neoantigen vaccine for the treatment of metastatic melanoma, non-small cell lung cancer, and bladder cancer; NEO-PTC-01, a neoantigen T cell therapy for the treatment of solid tumors; and NEO-SV-01, a neoantigen vaccine for the treatment of a subset of hormone receptor-positive breast cancer.
For more information, please visit www.neontherapeutics.com.
Investor Contact:Paul Cox, Corporate Affairs and Strategypcox@neontherapeutics.com617-337-4762
Media Contact:Stephanie Simon, Ten Bridge Communicationsstephanie@tenbridgecommunications.com 617-581-9333
1 Year Neon Therapeutics Chart |
1 Month Neon Therapeutics Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions